Literature DB >> 3494266

Epidermal growth factor in blood.

A P Savage, V K Chatterjee, H Gregory, S R Bloom.   

Abstract

The presence of receptors for epidermal growth factor (EGF) in a wide variety of human tissues and also some tumours indicates an as yet undefined role for EGF and it is therefore necessary to know precise concentrations in blood and other fluids. We have investigated the occurrence of EGF in the circulation and found that in platelet rich plasma, EGF levels were 51 +/- 5 pmol/l (mean +/- S.E.M., n = 6) while in platelet poor plasma levels were 2.9 +/- 0.9 pmol/1. In contrast, serum EGF was 37 +/- 7 pmol/l if separated at 30 min and rose to 117 +/- 5 pmol/l if separated at 270 min. Gel chromatography showed that all residual EGF immunoreactivity in platelet poor plasma resided in the high molecular weight form thought to be non biologically active. In serum, delay in separation resulted in an increase in the proportion of EGF immunoreactivity co-eluting with EGF standard. These results suggest that EGF in the circulation is associated with platelets and that the process of blood coagulation leads to release of free EGF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3494266     DOI: 10.1016/0167-0115(86)90019-4

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  8 in total

Review 1.  Role of epidermal growth factor in peptic ulcer healing.

Authors:  A Calabrò; S Milani; I Paladini; B Orsini; G Salvadori; C Surrenti
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

2.  Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis.

Authors:  D Birk; F Gansauge; S Gansauge; A Formentini; A Lucht; H G Beger
Journal:  Int J Pancreatol       Date:  1999-04

3.  Human recombinant insulin-like growth factor I. I. Development of a serum-free medium for clonal density assay of growth factors using BALB/c 3T3 mouse embryo fibroblasts.

Authors:  T L Riss; K P Karey; B D Burleigh; D Parker; D A Sirbasku
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

4.  The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF.

Authors:  Rui Chen; Ge Jin; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2017-04-28       Impact factor: 5.157

5.  Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol.

Authors:  R J Playford; J J Batten; T C Freeman; K Beardshall; D A Vesey; G C Fenn; J H Baron; J Calam
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

6.  Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells.

Authors:  Junzo Hisatsune; Eiki Yamasaki; Masaaki Nakayama; Daisuke Shirasaka; Hisao Kurazono; Yohtaro Katagata; Hiroyasu Inoue; Jiahuai Han; Jan Sap; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

7.  Effect of secretin and somatostatin on secretion of epidermal growth factor from Brunner's glands in the rat.

Authors:  P S Olsen; P Kirkegaard; S S Poulsen; E Nexø
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

8.  Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha.

Authors:  D Defeo-Jones; J Y Tai; R J Wegrzyn; G A Vuocolo; A E Baker; L S Payne; V M Garsky; A Oliff; M W Riemen
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.